1. Home
  2. LNN vs RCUS Comparison

LNN vs RCUS Comparison

Compare LNN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNN
  • RCUS
  • Stock Information
  • Founded
  • LNN 1954
  • RCUS 2015
  • Country
  • LNN United States
  • RCUS United States
  • Employees
  • LNN N/A
  • RCUS N/A
  • Industry
  • LNN Industrial Machinery/Components
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNN Industrials
  • RCUS Health Care
  • Exchange
  • LNN Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • LNN 1.5B
  • RCUS 1.4B
  • IPO Year
  • LNN 1988
  • RCUS 2018
  • Fundamental
  • Price
  • LNN $135.63
  • RCUS $14.15
  • Analyst Decision
  • LNN Buy
  • RCUS Buy
  • Analyst Count
  • LNN 2
  • RCUS 12
  • Target Price
  • LNN $136.00
  • RCUS $34.50
  • AVG Volume (30 Days)
  • LNN 77.3K
  • RCUS 583.4K
  • Earning Date
  • LNN 01-07-2025
  • RCUS 02-19-2025
  • Dividend Yield
  • LNN 1.06%
  • RCUS N/A
  • EPS Growth
  • LNN N/A
  • RCUS N/A
  • EPS
  • LNN 6.22
  • RCUS N/A
  • Revenue
  • LNN $611,997,000.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • LNN $10.05
  • RCUS $127.65
  • Revenue Next Year
  • LNN $3.81
  • RCUS N/A
  • P/E Ratio
  • LNN $21.39
  • RCUS N/A
  • Revenue Growth
  • LNN N/A
  • RCUS 119.17
  • 52 Week Low
  • LNN $109.27
  • RCUS $13.51
  • 52 Week High
  • LNN $136.30
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • LNN 72.68
  • RCUS 39.00
  • Support Level
  • LNN $116.53
  • RCUS $13.81
  • Resistance Level
  • LNN $124.22
  • RCUS $14.45
  • Average True Range (ATR)
  • LNN 3.05
  • RCUS 0.57
  • MACD
  • LNN 1.81
  • RCUS -0.06
  • Stochastic Oscillator
  • LNN 96.61
  • RCUS 30.40

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: